{"nct_id":"NCT01856218","title":"An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of Study Drug UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)","status":"COMPLETED","status_verified_date":"2018-12","start_date":"2013-11","start_date_type":null,"primary_completion_date":"2016-07","primary_completion_date_type":"ACTUAL","completion_date":"2016-07","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["RARE"]}